Conformational preorganization, hydration, and nucleic acid duplex stability

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 2, 1998, Pages 123-128

  Egli, Martin ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; DOUBLE STRANDED RNA; NUCLEIC ACID;

CONFERENCE PAPER; DNA CONFORMATION; HYDRATION; MOLECULAR STABILITY; PRIORITY JOURNAL; RNA CONFORMATION;

EID: 0031900834     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.123     Document Type: Conference Paper

References (18)

1. BÄSCHLIN, D.K., HYRUP, B., BENNER, S.A., and RICHERT, C. (1996). Chimera of dimethylene sulfone-, methyl sulfide-, and methyl sulfoxide-linked ribonucleotides and DNA. J. Org. Chem. 61, 7620-7626.
2. BÖHRINGER, M., ROTH, H.-J., HUNZIKER, J., GÖBEL, M., KRISHNAN, R., GIGER, A., SCHWEIZER, B., SCHREIBER, J., LEUMANN, C., and ESCHENMOSER, A. (1992). Why pentose and not hexose nucleic acids? Part II. Helv. Chim. Acta 75, 1416-1477.
3. BRESLOW, R. (1998). Biomimetic chemistry: a frontier at the chemistry/biology interface. Chem. Biol. 5, R27-R28.
4. CHEN, J.-K., SCHULTZ, R.G., LLOYD, D.H., and GRYAZNOV, S.M. (1995). Synthesis of oligodeoxyribonucleotide N3′ → P5′ phosphoramidates. Nucleic Acids Res. 23, 2661-2668.
5. DING, D., GRYAZNOV, S.M., LLOYD, D.H., CHANDRASEKARAN, S., YAO, S., RATMEYER, L., PAN, Y., and WILSON, W.D. (1996). An oligodeoxyribonucleotide N3′ → P5′ phosphoramidate duplex forms an A-type helix in solution. Nucleic Acids Res. 24, 354-360.
6. EGLI, M. (1996). Structural aspects of nucleic acid analogs and antisense oligonucleotides. Angew. Chem. Int. Ed. Engl. 35, 1894-1909.
7. EGLI, M., PORTMANN, S., and USMAN, N. (1996). RNA hydration: A detailed look. Biochemistry 35, 8489-8494.
8. ESCHENMOSER, A., and DOBLER, M. (1992). Why pentose and not hexose nucleic acids? Part I. Helv. Chim. Acta 75, 218-259.
9. ESCHENMOSER, A., and KISAKÜREK, M.V. (1996). Chemistry and the origin of life. Helv. Chim. Acta 79, 1249-1259.
10. ESCHENMOSER, A., and LOEWENTHAL, E. (1992). Chemistry of potentially prebiological natural products. Chem. Soc. Rev. 21, 1-16.
11. ESCUDÉ, C., GIOVANNANGELI, C., SUN, J.-S., LLOYD, D.H., CHEN, J.-K., GRYAZNOV, S.M., GARESTIER, T., and HELENE, C. (1996). Stable triple helices formed by oligonucleotide N3′ → P5′ phosphoramidates inhibit transcription elongation. Proc. Nat. Acad. Sci. USA 93, 4365-4369.
12. FRANKLIN, R.E., and GOSLING, R.G. (1953). Molecular configuration in sodium thymonucleate. Nature 171, 740-741.
13. FREIER, S.M., and ALTMANN, K.-H. (1997). The ups and downs of nucleic acid duplex stability. Structure-stability studies in chemically modified DNA:RNA duplexes. Nucleic Acids Res. 25, 4429-4443.
14. GIOVANNANGELI, C., DIVIACCO, S., LABROUSSE, V., GRYAZNOV, S., CHARNEAU, P., and HÉLÈNE, C. (1997). Accessibility of nuclear DNA to triplex-forming oligonucleotides: The integrated HIV-1 provirus as a target. Proc. Natl. Acad. Sci. USA 94, 79-84.
15. SCHULTZ, R.G., and GRYAZNOV, S.M. (1996). Oligo-2′-fluoro-2′-deoxynucleotide N3′ → P5′ phosphoramidates: Synthesis and properties. Nucleic Acids Res. 24, 2966-2973.
16. SKORSKI, T., PERROTTI, D., NIEBOROWSKA-SKORSKI, M., GRYAZNOV, S., and CALABRETTA, B. (1997). Antileukemia effect of c-myc N3′ → P5′ phosphoramidate antisense oligonucleotides in vivo. Proc. Natl. Acad. Sci. USA 94, 3966-3971.
17. TERESHKO, V., GRYAZNOV, S., and EGLI, M. (1998). Consequences of replacing the DNA 3′-oxygen by an amino group: High-resolution crystal structure of a fully modified N3′ → P5′ phosphoramidate DNA dodecamer duplex. J. Am. Chem. Soc. 120, 269-283.
18. VESNAVER, G., and BRESLAUER, K.J. (1991). The contribution of DNA single-stranded order to the thermodynamics of duplex formation. Proc. Natl. Acad. Sci. USA 88, 3569-3573.